SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?


To: gaddis who wrote (618)4/17/1998 8:25:00 PM
From: erin4  Read Replies (1) | Respond to of 834
 
A stock analyst from a large New York firm recommended TXB this evening on The Nightly Business Report TV show on PBS. He says there should be several major announcements in May and June, one being an FDA drug approval. His target price is $16 a share.